ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 75 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $82,000 | -91.0% | 26,030 | -82.6% | 0.00% | -90.9% |
| Q3 2018 | $908,000 | -89.7% | 150,000 | -91.0% | 0.02% | -87.6% |
| Q2 2018 | $8,809,000 | -39.2% | 1,661,986 | -33.5% | 0.18% | -24.4% |
| Q1 2018 | $14,500,000 | +53.4% | 2,500,000 | -7.4% | 0.23% | +38.5% |
| Q4 2017 | $9,450,000 | +7709.9% | 2,700,000 | +8039.9% | 0.17% | +8350.0% |
| Q3 2017 | $121,000 | +45.8% | 33,170 | 0.0% | 0.00% | +100.0% |
| Q2 2017 | $83,000 | -7.8% | 33,170 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $90,000 | -6.2% | 33,170 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $96,000 | – | 33,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |